Anupam Rasayan India Ltd
ANURASAnupam Rasayan India Ltd
ANURASPrice Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
121.11 | 2.89 | 0.16% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
31.29 | 3.55 | 1.30% |
Forecast & Ratings
Detailed Forecast from 8 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Anupam Rasayan is engaged in the business of custom synthesis and manufacturing of specialty chemicals in India.
Investor Presentation
View olderÂPeers
Compare with peersÂGujarat Fluorochemicals Ltd
Vinati Organics Ltd
Navin Fluorine International Ltd
Akzo Nobel India Ltd
Aarti Industries Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 837.50 | 520.96 | 539.76 | 837.50 | 1,081.76 | 1,611.95 | 1,505.32 | 1,267.12 | ||||||||
Raw Materials | 617.30 | 263.48 | 296.16 | 469.36 | 691.70 | 767.59 | 693.14 | 939.33 | ||||||||
Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.77 | 1.17 | ||||||||||
Employee Cost | 18.59 | 21.09 | 32.44 | 48.50 | 68.90 | 75.14 | ||||||||||
Selling & Administrative Expenses | 26.92 | 28.87 | 37.11 | 56.20 | 80.58 | 86.67 | ||||||||||
Operating & Other expenses | 99.37 | 48.01 | 78.39 | -27.44 | 252.70 | 238.29 | ||||||||||
EBITDA | 220.20 | 112.60 | 145.63 | 220.20 | 312.80 | 441.41 | 410.91 | 327.79 | ||||||||
Depreciation/Amortization | 51.65 | 22.53 | 28.71 | 51.65 | 60.12 | 71.08 | 79.70 | 83.51 | ||||||||
PBIT | 168.55 | 90.07 | 116.92 | 168.55 | 252.68 | 370.33 | 331.21 | 244.28 | ||||||||
Interest & Other Items | 68.54 | 24.35 | 45.26 | 68.54 | 30.83 | 62.66 | 89.43 | 100.24 | ||||||||
PBT | 100.01 | 65.72 | 71.66 | 100.01 | 221.85 | 307.67 | 241.78 | 144.04 | ||||||||
Taxes & Other Items | 29.71 | 16.47 | 18.47 | 29.71 | 69.68 | 126.82 | 113.17 | 74.15 | ||||||||
Net Income | 70.30 | 49.25 | 53.19 | 70.30 | 152.17 | 180.85 | 128.61 | 69.89 | ||||||||
EPS | 8.56 | 9.85 | 10.64 | 9.38 | 15.20 | 17.41 | 11.84 | 6.37 | ||||||||
DPS | — | 0.00 | 0.00 | 0.50 | 1.00 | 2.50 | 1.25 | 1.25 | ||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.05 | 0.07 | 0.14 | 0.11 | 0.20 |
Company Updates
Peers & Comparison
MaterialsSpecialty Chemicals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Anupam Rasayan India Ltd | 65.82 | 2.89 | 0.16% |
Gujarat Fluorochemicals Ltd | 112.50 | 8.24 | 0.07% |
Vinati Organics Ltd | 60.02 | 7.87 | 0.37% |
Navin Fluorine International Ltd | 66.87 | 7.59 | 0.41% |
Price Comparison
Compare ANURAS with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Anupam Rasayan India Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
Quant Small Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.8871% | Percentage of the fund’s portfolio invested in the stock 0.56% | Change in the portfolio weight of the stock over the last 3 months -0.07% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 26/98 (-4) |
Motilal Oswal Nifty Microcap 250 Index Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0500% | Percentage of the fund’s portfolio invested in the stock 0.23% | Change in the portfolio weight of the stock over the last 3 months 0.23% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 301/309 (+8) |
Groww Nifty Total Market Index Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0003% | Percentage of the fund’s portfolio invested in the stock 0.01% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 787/801 (-43) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 17, 2024
Dividend/Share
₹0.75
Ex DateEx Date
Sep 17, 2024
Cash Dividend
Ex DateEx DateNov 20, 2023
Dividend/Share
₹0.50
Ex DateEx Date
Nov 20, 2023
Cash Dividend
Ex DateEx DateMay 15, 2023
Dividend/Share
₹1.50
Ex DateEx Date
May 15, 2023
Cash Dividend
Ex DateEx DateFeb 8, 2023
Dividend/Share
₹0.60
Ex DateEx Date
Feb 8, 2023
Cash Dividend
Ex DateEx DateSep 2, 2022
Dividend/Share
₹1.00
Ex DateEx Date
Sep 2, 2022
The Board of Anupam Rasayan India at its meeting held on 03 December 2024 has approved the appointment of Anand Rajeshwarrao Chatorikar (DIN: 03508333) as an Additional Director designated as an Independent Director of the Company, not liable to retire by rotation, with effect from 03 December 2024. Powered by Capital Market - Live
Profit before tax (PBT) fell 51.87% YoY to Rs 34.01 crore in Q2 FY25. EBITDA stood at Rs 82.4 crore, registering the de-growth of 25.7% as compared with Rs 110.9 crore posted in corresponding quarter last year. EBITDA margin remained flat at 28% during the quarter. Meanwhile, the company's wholly owned subsidiary named Anupam General Trading FZE has been registered in Jebel Ali Free Zone (JAFZA), Dubai, UAE. Anupam General Trading FZE is registered with initial capital of AED 20,000. The objective of Anupam General Trading FZE is the trading and storage of chemicals including handling of distribution and sales of chemicals for export markets. Anand Desai, managing director, Anupam Rasayan, said, 'In Q2FY25, we were nearing the end of a demand slump in the Agro segment, and we are now seeing a good recovery. The Pharma and Polymer segments, meanwhile, have been showing robust growth, fuelled by the launch of over 17 new molecules in FY24 and 3 additional molecules in H1FY25. As these products gain traction, we expect their contribution to grow. Additionally, the planned launch of more than 3 new molecules in the coming months should further accelerate growth in these areas. Our consolidated operating revenue for the quarter was Rs 294 crore, representing a QoQ growth of 14%, with a stable EBITDA margin of 28% in Q2FY25. We anticipate revenue to normalize as volumes increase in the latter half of the year. With the new capacity, scaling of recently launched fluorinated molecules, and signed LOIs and contracts, we are optimistic about strong growth over the medium term. Anupam Rasayan India is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India. Its business verticals are life science related specialty chemicals comprising products related to agrochemicals, personal care and pharmaceuticals, and other specialty chemicals, comprising specialty pigment and dyes, and polymer additives.Powered by Capital Market - Live
Profit before tax (PBT) fell 51.87% YoY to Rs 34.01 crore in Q2 FY25. EBITDA stood at Rs 82.4 crore, registering the de-growth of 25.7% as compared with Rs 110.9 crore posted in corresponding quarter last year. EBITDA margin remained flat at 28% during the quarter. Meanwhile, the company's wholly owned subsidiary named Anupam General Trading FZE has been registered in Jebel Ali Free Zone (JAFZA), Dubai, UAE. Anupam General Trading FZE is registered with initial capital of AED 20,000. The objective of Anupam General Trading FZE is the trading and storage of chemicals including handling of distribution and sales of chemicals for export markets. Anand Desai, managing director, Anupam Rasayan, said, 'In Q2FY25, we were nearing the end of a demand slump in the Agro segment, and we are now seeing a good recovery. The Pharma and Polymer segments, meanwhile, have been showing robust growth, fuelled by the launch of over 17 new molecules in FY24 and 3 additional molecules in H1FY25. As these products gain traction, we expect their contribution to grow. Additionally, the planned launch of more than 3 new molecules in the coming months should further accelerate growth in these areas. Our consolidated operating revenue for the quarter was Rs 294 crore, representing a QoQ growth of 14%, with a stable EBITDA margin of 28% in Q2FY25. We anticipate revenue to normalize as volumes increase in the latter half of the year. With the new capacity, scaling of recently launched fluorinated molecules, and signed LOIs and contracts, we are optimistic about strong growth over the medium term. Anupam Rasayan India is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India. Its business verticals are life science related specialty chemicals comprising products related to agrochemicals, personal care and pharmaceuticals, and other specialty chemicals, comprising specialty pigment and dyes, and polymer additives. The scrip advanced 1.69% to settle at Rs 734.55 on Thursday, 14 November 2024.Powered by Capital Market - Live
Anupam Rasayan India will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Anupam Rasayan India approved the issue and allotment of 37,804 fully paid-up equity shares of face value of INR 10/- each under Anupam ' Employees Stock Option Plan 2020 of the Company pursuant to exercise of Options by the eligible employees. Powered by Capital Market - Live
Anupam Rasayan India announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
JSW Energy Ltd, Usha Martin Ltd, Alembic Pharmaceuticals Ltd, KSB Ltd are among the other stocks to see a surge in volumes on BSE today, 09 September 2024.Anupam Rasayan India Ltd clocked volume of 5926 shares by 10:46 IST on BSE, a 2.82 times surge over two-week average daily volume of 2099 shares. The stock lost 0.01% to Rs.762.35. Volumes stood at 4504 shares in the last session.JSW Energy Ltd recorded volume of 2.96 lakh shares by 10:46 IST on BSE, a 2.82 times surge over two-week average daily volume of 1.05 lakh shares. The stock gained 3.19% to Rs.732.20. Volumes stood at 52490 shares in the last session.Usha Martin Ltd witnessed volume of 96010 shares by 10:46 IST on BSE, a 2.53 times surge over two-week average daily volume of 37895 shares. The stock increased 3.00% to Rs.361.85. Volumes stood at 51303 shares in the last session.Alembic Pharmaceuticals Ltd clocked volume of 44024 shares by 10:46 IST on BSE, a 2.5 times surge over two-week average daily volume of 17591 shares. The stock gained 4.72% to Rs.1,159.90. Volumes stood at 32541 shares in the last session.KSB Ltd saw volume of 10906 shares by 10:46 IST on BSE, a 2.25 fold spurt over two-week average daily volume of 4856 shares. The stock dropped 3.42% to Rs.865.35. Volumes stood at 2143 shares in the last session.Powered by Capital Market - Live
Anupam Rasayan India has fixed 18 September 2024 as record date for final dividend, if declared. Powered by Capital Market - Live
Net profit of Anupam Rasayan India declined 89.84% to Rs 3.92 crore in the quarter ended June 2024 as against Rs 38.60 crore during the previous quarter ended June 2023. Sales declined 34.21% to Rs 254.20 crore in the quarter ended June 2024 as against Rs 386.39 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales254.20386.39 -34 OPM %20.9226.25 - PBDT36.8695.98 -62 PBT16.2277.30 -79 NP3.9238.60 -90 Powered by Capital Market - Live
Anupam Rasayan India will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 23.64%, vs industry avg of 6.15%
Increasing Market Share
Over the last 5 years, market share increased from 0.94% to 1.78%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 21.16%, vs industry avg of -1.3%